Delphia (Usa) Inc. Intercept Pharmaceuticals, Inc. Transaction History

Delphia (Usa) Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$11.61 - $16.11 $10,611 - $14,724	-914 Reduced 7.97%	10,552 $130,000
Q3 2022 Nov 14, 2022	SELL	$12.21 - $19.7 $68,901 - $111,167	-5,643 Reduced 32.98%	11,466 $160,000
Q2 2022 Aug 15, 2022	BUY	$11.23 - $19.59 $8,489 - $14,810	756 Added 4.62%	17,109 $236,000
Q1 2022 May 16, 2022	BUY	$13.37 - $17.79 $47,102 - $62,674	3,523 Added 27.46%	16,353 $266,000
Q4 2021 Feb 14, 2022	BUY	$14.28 - $19.53 $183,212 - $250,569	12,830 New	12,830 $209,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Delphia (Usa) Inc., based on Form 13F filings with the SEC.

Stay updated on Delphia (Usa) Inc. with notifications on news.